Literature DB >> 35729274

Rational design of a disulfide bridge increases the thermostability of microbial transglutaminase.

Mototaka Suzuki1, Masayo Date1, Tatsuki Kashiwagi1, Eiichiro Suzuki1,2, Keiichi Yokoyama3,4.   

Abstract

Microbial transglutaminase (MTG) has numerous industrial applications in the food and pharmaceutical sectors. Unfortunately, the thermostability of MTG is too low to tolerate the desired conditions used in many of these commercial processes. In a previous study, we used protein engineering to improve the thermostability of MTG. Specifically, we generated a T7C/E58C mutant of MTG from Streptomyces mobaraensis that displayed enhanced resistance to thermal inactivation. In this study, a rational structure-based approach was adopted to introduce a disulfide bridge to further increase the thermostability of MTG. In all, four new mutants, each containing a novel disulfide bond, were engineered. Of these four mutants, D3C/G283C showed the most promising thermostability with a significantly higher ∆T50 (defined as the temperature of incubation at which 50% of the initial activity remains) of + 9 °C by comparison to wild-type MTG. Indeed, D3C/G283C combined enhanced thermostability with a 2.1-fold increased half-life at 65 °C compared with the wild-type enzyme. By structure-based rational design, we were able to create an MTG variant which might be useful for expanding the scope of application in food. KEY POINTS: • Microbial transglutaminase (MTG) is an enzyme used in many food applications • The applicability of MTG to various industrial processes other than the food sector is being investigated • Improvement of thermostability was confirmed for the disulfide bridge mutant D3C/G283C.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Disulfide bridge; Heat resistance; Microbial transglutaminase; Protein modification

Mesh:

Substances:

Year:  2022        PMID: 35729274     DOI: 10.1007/s00253-022-12024-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  33 in total

1.  A continuous spectrophotometric linked enzyme assay for transglutaminase activity.

Authors:  N Day; J W Keillor
Journal:  Anal Biochem       Date:  1999-10-01       Impact factor: 3.365

2.  Increased thermostability of microbial transglutaminase by combination of several hot spots evolved by random and saturation mutagenesis.

Authors:  Karin Buettner; Thomas C Hertel; Markus Pietzsch
Journal:  Amino Acids       Date:  2011-08-24       Impact factor: 3.520

Review 3.  Directed evolution 2.0: improving and deciphering enzyme properties.

Authors:  Feng Cheng; Leilei Zhu; Ulrich Schwaneberg
Journal:  Chem Commun (Camb)       Date:  2015-06-18       Impact factor: 6.222

Review 4.  Bioengineering of microbial transglutaminase for biomedical applications.

Authors:  Soo Khim Chan; Theam Soon Lim
Journal:  Appl Microbiol Biotechnol       Date:  2019-02-25       Impact factor: 4.813

5.  Enzymatic activity and thermoresistance of improved microbial transglutaminase variants.

Authors:  B Böhme; B Moritz; J Wendler; T C Hertel; C Ihling; W Brandt; M Pietzsch
Journal:  Amino Acids       Date:  2019-07-26       Impact factor: 3.520

Review 6.  Microbial transglutaminase for biotechnological and biomedical engineering.

Authors:  Lukas Deweid; Olga Avrutina; Harald Kolmar
Journal:  Biol Chem       Date:  2019-02-25       Impact factor: 3.915

Review 7.  Transglutaminases.

Authors:  J E Folk
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

8.  Conserved residues in the extracellular loops of short-wavelength cone visual pigments.

Authors:  Min-Hsuan Chen; Daniel J Sandberg; Kunnel R Babu; Jose Bubis; Arjun Surya; Lavoisier S Ramos; Heidi J Zapata; Jhenny F Galan; Megan N Sandberg; Robert R Birge; Barry E Knox
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

Review 9.  Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.

Authors:  Angelo Fontana; Barbara Spolaore; Anna Mero; Francesco M Veronese
Journal:  Adv Drug Deliv Rev       Date:  2007-08-16       Impact factor: 15.470

Review 10.  A recent update on the use of microbial transglutaminase for the generation of biotherapeutics.

Authors:  N Doti; A Caporale; Alessandra Monti; A Sandomenico; Fabio Selis; M Ruvo
Journal:  World J Microbiol Biotechnol       Date:  2020-03-14       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.